Discussion
1. Compare and contrast Shareholder Value at Risk (SVAR) with premium risk.
2. Is there any information on how accurate a tool SVAR is when it comes to measuring the synergy risk?
3. Are there any guidelines a company executive should consider when evaluating SVAR?